Sfoglia per Autore  

opzioni
Mostrati risultati da 1 a 20 di 69
Titolo Data di pubblicazione Autore(i) File
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 1-gen-1997 Cirafici, Am; Salvatore, Giuliana; DE VITA, G; Carlomagno, F; Dathan, Na; Visconti, R; Melillo, Rm; Fusco, A; Santoro, M.
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 1-gen-1997 Carlomagno, F; Salvatore, Giuliana; Cirafici, Am; DE VITA, G; Melillo, Rm; DE FRANCISCIS, V; Billaud, M; Fusco, A; Santoro, M.
Molecular biology of the MEN2 gene 1-gen-1998 Santoro, M; Melillo, Rm; Carlomagno, F; Visconti, R; DE VITA, G; Salvatore, Giuliana; Lupoli, G; Fusco, A; Vecchio, G.
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 1-gen-1998 Carlomagno, F; Melillo, Rm; Visconti, R; Salvatore, Giuliana; DE VITA, G; Lupoli, G; Yu, Y; Jing, S; Vecchio, G; Fusco, A; Santoro, M.
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 1-gen-1998 Tallini, G; Santoro, M; Helie, M; Carlomagno, F; Salvatore, Giuliana; Chiappetta, G; Carcangiu, Ml; Fusco, A.
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 1-gen-1999 H., THOMAS GA; Bunnell, H; Cook, Ha; Williams, Ed; Nerovnya, A; Cherstvoy, Ed; Tronko, Nd; Bogdanova, Ti; Chiappetta, G; Viglietto, G; Pentimalli, F; Salvatore, Giuliana; Fusco, A; Santoro, M; Vecchio, G.
Different mutations of the RET gene cause different human tumoral diseases 1-gen-1999 Santoro, M; Melillo, Rm; Carlomagno, F; Visconti, R; DE VITA, G; Salvatore, Giuliana; Fusco, A; Vecchio, G.
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 1-gen-2000 Salvatore, D; Barone, Mv; Salvatore, Giuliana; Melillo, Rm; Chiappetta, G; Mineo, A; Fenzi, G; Vecchio, G; Fusco, A; Santoro, M.
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 1-gen-2000 Viglietto, G; Dolci, S; Bruni, P; Baldassarre, G; Chiariotti, L; Melillo, Rm; Salvatore, Giuliana; Chiappetta, G; Sferratore, F; Fusco, A; Santoro, M.
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 1-gen-2000 Giannini, R; Salvatore, Giuliana; Monaco, C; Sferratore, F; Pollina, L; Pacini, F; Basolo, F; Fusco, A; Santoro, M.
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 1-gen-2001 Bera, Tk; Lee, S; Salvatore, Giuliana; Lee, B; Pastan, I.
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 1-gen-2002 Salvatore, Giuliana; Beers, R; Margulies, I; Kreitman, Rj; Pastan, I.
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 1-gen-2002 Bera, Tk; Maitra, R; Iavarone, C; Salvatore, Giuliana; Kumar, V; Vincent, Jj; Sathyanarayana, Bk; Duray, P; Lee, Bk; Pastan, I.
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 1-gen-2002 Basolo, F; Giannini, R; Monaco, C; Melillo, Rm; Carlomagno, F; Pancrazi, M; Salvatore, Giuliana; Chiappetta, G; Pacini, F; Elisei, R; Miccoli, P; Pinchera, A; Fusco, A; Santoro, M.
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 1-gen-2002 Salvatore, Giuliana; Nagata, S; Billaud, M; Santoro, M; Vecchio, G; Pastan, I.
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 1-gen-2002 Baldassarre, G; Bruni, P; Boccia, A; Salvatore, Giuliana; Melillo, Rm; Motti, Maria Letizia; Napolitano, M; Belletti, B; Fusco, A; Santoro, M; Viglietto, G.
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 1-gen-2003 Nikiforova, Mn; Kimura, Et; Gandhi, M; Biddinger, Pw; Knauf, Ja; Basolo, F; Zhu, Z; Giannini, R; Salvatore, Giuliana; Fusco, A; Santoro, M; Fagin, Ja; Nikiforov, Ye
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 1-gen-2003 Nagata, S; Salvatore, Giuliana; Pastan,
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 1-gen-2004 Nikiforova, Mn; Ciampi, R; Salvatore, Giuliana; Santoro, M; Gandhi, M; Knauf, Ja; Thomas, Ga; Jeremiah, S; Bogdanova, Ti; Tronko, Md; Fagin, Ja; Nikiforov, Ye
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 1-gen-2004 Lima, J; Trovisco, V; Soares, P; Maximo, V; Magalhaes, J; Salvatore, Giuliana; Santoro, M; Bogdanova, T; Tronko, M; Abrosimov, A; Jeremiah, S; Thomas, G; Williams, D; SOBRINHO SIMOES, M.
Mostrati risultati da 1 a 20 di 69
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile